The coagulopathy of acute liver failure and implications for intracranial pressure monitoring

被引:42
作者
Munoz, Santiago J. [1 ]
Reddy, K. Rajender [2 ]
Lee, William [3 ]
机构
[1] Albert Einstein Med Ctr, Div Hepatol, Philadelphia, PA 19141 USA
[2] Univ Penn, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[4] Acute Liver Failure Study Grp, Dallas, TX USA
关键词
coagulopathy; liver; hepatitis; plasma; factor VII; clotting; intracranial pressure; cerebral edema; hypothermia;
D O I
10.1007/s12028-008-9087-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction The development of coagulopathy in acute liver failure (ALF) is universal. The severity of the coagulopathy is often assessed by determination of the prothrombin time and International Normalized Ratio (INR). Discussion In more than 1,000 ALF cases, the severity of the coagulopathy was moderate in 81% (INR 1.5-5.0), severe in 14% (INR 5.0-10.0), and very severe in 5% (INR > 10.0). Certain etiologies were associated with more severe coagulopathy, whereas ALF caused by fatty liver of pregnancy had the least severe coagulopathy. Methods Management consisted of transfusions of FFP in 92%. Overall, FFP administered during the first week of admission amounted to 13.7 +/- 15 units. Results Patients who received an ICP monitor had significantly more FFP transfused than those managed without ICP monitor (22.7 +/- 2.4 vs. 12.3 +/- 0.8 units FFP; P < 0.001). Only a minority of patients developed gastrointestinal bleeding or had an intracranial pressure monitor installed. Conclusion Further research is necessary to explore the reasons clinicians transfuse ALF patients with large amounts of FFP in the absence of active bleeding or invasive procedures.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 31 条
[1]   Use and outcome of liver transplantation in acetaminophen-induced acute liver failure [J].
Bernal, W ;
Wendon, J ;
Rela, M ;
Heaton, N ;
Williams, R .
HEPATOLOGY, 1998, 27 (04) :1050-1055
[2]   COMPLICATIONS OF INTRACRANIAL-PRESSURE MONITORING IN FULMINANT HEPATIC-FAILURE [J].
BLEI, AT ;
OLAFSSON, S ;
WEBSTER, S ;
LEVY, R .
LANCET, 1993, 341 (8838) :157-158
[3]   Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management [J].
Caldwell, Stephen H. ;
Hoffman, Maureane ;
Lisman, Ton ;
Macik, B. Gail ;
Northup, Patrick G. ;
Reddy, K. Rajender ;
Tripodi, Armando ;
Sanyal, Arun J. .
HEPATOLOGY, 2006, 44 (04) :1039-1046
[4]  
CLARK R, 1973, SCAND J GASTROENTERO, V8, P63
[5]  
DEVLIN J, 1995, HEPATOLOGY, V21, P1018
[6]  
DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D
[7]   Liver transplantation for fulminant hepatic failure - Experience with more than 200 patients over a 17-year period [J].
Farmer, DG ;
Anselmo, DM ;
Ghobrial, RM ;
Yersiz, H ;
McDiarmid, SV ;
Cao, C ;
Weaver, M ;
Figueroa, J ;
Khan, K ;
Vargas, J ;
Saab, S ;
Han, S ;
Durazo, F ;
Goldstein, L ;
Holt, C ;
Busuttil, RW .
ANNALS OF SURGERY, 2003, 237 (05) :666-675
[8]   EARLY CHANGES IN COAGULATION FOLLOWING A PARACETAMOL OVERDOSE AND A CONTROLLED TRIAL OF FRESH FROZEN PLASMA THERAPY [J].
GAZZARD, BG ;
HENDERSON, JM ;
WILLIAMS, R .
GUT, 1975, 16 (08) :617-620
[9]   Haemostatic abnormalities in patients with liver disease [J].
Lisman, T ;
Leebeek, FWG ;
de Groot, PG .
JOURNAL OF HEPATOLOGY, 2002, 37 (02) :280-287
[10]   Hemostatic alterations in liver disease: A review on pathophysiology, clinical consequences, and treatment [J].
Lisman, Ton ;
Leebeek, Frank W. G. .
DIGESTIVE SURGERY, 2007, 24 (04) :250-258